May 24, 2023 07:01 AM EDTUpdated 07:40 AM

PTC cuts gene therapy programs, discloses PhIII fail in Friedreich's ataxia and CFO exit

PTC Therapeutics disclosed a string of disappointing news late Tuesday, revealing a Phase III flop, a pipeline reorg to cut

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

PTC cuts gene ther­a­py pro­grams, dis­clos­es PhI­II fail in Friedre­ich's atax­ia and CFO ex­it